Diapid
Internal ID | 1a163fd7-ae69-4227-9977-0a19a8c87510 |
Taxonomy | Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Peptides > Oligopeptides |
IUPAC Name | (2S)-N-[6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide |
SMILES (Canonical) | C1CC(N(C1)C(=O)C2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)N)C(=O)NC(CCCCN)C(=O)NCC(=O)N |
SMILES (Isomeric) | C1C[C@H](N(C1)C(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)N)C(=O)NC(CCCCN)C(=O)NCC(=O)N |
InChI | InChI=1S/C46H65N13O12S2/c47-17-5-4-9-29(40(65)52-22-38(51)63)54-45(70)35-10-6-18-59(35)46(71)34-24-73-72-23-28(48)39(64)55-31(20-26-11-13-27(60)14-12-26)43(68)56-32(19-25-7-2-1-3-8-25)42(67)53-30(15-16-36(49)61)41(66)57-33(21-37(50)62)44(69)58-34/h1-3,7-8,11-14,28-35,60H,4-6,9-10,15-24,47-48H2,(H2,49,61)(H2,50,62)(H2,51,63)(H,52,65)(H,53,67)(H,54,70)(H,55,64)(H,56,68)(H,57,66)(H,58,69)/t28-,29?,30-,31-,32-,33-,34-,35-/m0/s1 |
InChI Key | BJFIDCADFRDPIO-ZCCHBGLBSA-N |
Popularity | 13 references in papers |
Molecular Formula | C46H65N13O12S2 |
Molecular Weight | 1056.20 g/mol |
Exact Mass | 1055.43170691 g/mol |
Topological Polar Surface Area (TPSA) | 476.00 Ų |
XlogP | -3.90 |
Atomic LogP (AlogP) | -4.33 |
H-Bond Acceptor | 16 |
H-Bond Donor | 13 |
Rotatable Bonds | 19 |
8-L-Lysine vasopressin |
Pressyn |
3-(Phenylalanine)-8-lysine oxytocin |
Q60496436 |
6-amino-2-{[(2S)-1-{[(4R,7S,10S,13S,16S,19R)-19-amino-13-benzyl-10-(2-carbamoylethyl)-7-(carbamoylmethyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}pyrrolidin-2-yl]formamido}-N-(carbamoylmethyl)hexanamide |

Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | + | 0.5899 | 58.99% |
Caco-2 | - | 0.8711 | 87.11% |
Blood Brain Barrier | - | 0.7000 | 70.00% |
Human oral bioavailability | - | 0.8429 | 84.29% |
Subcellular localzation | Mitochondria | 0.5294 | 52.94% |
OATP2B1 inhibitior | - | 0.7168 | 71.68% |
OATP1B1 inhibitior | + | 0.8708 | 87.08% |
OATP1B3 inhibitior | + | 0.9354 | 93.54% |
MATE1 inhibitior | - | 0.8600 | 86.00% |
OCT2 inhibitior | - | 0.7750 | 77.50% |
BSEP inhibitior | + | 0.9049 | 90.49% |
P-glycoprotein inhibitior | + | 0.7475 | 74.75% |
P-glycoprotein substrate | + | 0.8672 | 86.72% |
CYP3A4 substrate | + | 0.7302 | 73.02% |
CYP2C9 substrate | - | 1.0000 | 100.00% |
CYP2D6 substrate | - | 0.7868 | 78.68% |
CYP3A4 inhibition | - | 0.7185 | 71.85% |
CYP2C9 inhibition | - | 0.7660 | 76.60% |
CYP2C19 inhibition | - | 0.7565 | 75.65% |
CYP2D6 inhibition | - | 0.8606 | 86.06% |
CYP1A2 inhibition | - | 0.9358 | 93.58% |
CYP2C8 inhibition | + | 0.7009 | 70.09% |
CYP inhibitory promiscuity | - | 0.8301 | 83.01% |
UGT catelyzed | + | 0.8000 | 80.00% |
Carcinogenicity (binary) | - | 0.7300 | 73.00% |
Carcinogenicity (trinary) | Non-required | 0.6247 | 62.47% |
Eye corrosion | - | 0.9865 | 98.65% |
Eye irritation | - | 0.8989 | 89.89% |
Skin irritation | - | 0.7550 | 75.50% |
Skin corrosion | - | 0.9276 | 92.76% |
Ames mutagenesis | - | 0.6770 | 67.70% |
Human Ether-a-go-go-Related Gene inhibition | + | 0.6548 | 65.48% |
Micronuclear | + | 0.9400 | 94.00% |
Hepatotoxicity | - | 0.8625 | 86.25% |
skin sensitisation | - | 0.8597 | 85.97% |
Respiratory toxicity | + | 0.9111 | 91.11% |
Reproductive toxicity | + | 0.9556 | 95.56% |
Mitochondrial toxicity | + | 0.9000 | 90.00% |
Nephrotoxicity | - | 0.8091 | 80.91% |
Acute Oral Toxicity (c) | III | 0.4958 | 49.58% |
Estrogen receptor binding | + | 0.8162 | 81.62% |
Androgen receptor binding | + | 0.6639 | 66.39% |
Thyroid receptor binding | + | 0.5227 | 52.27% |
Glucocorticoid receptor binding | - | 0.6015 | 60.15% |
Aromatase binding | + | 0.6366 | 63.66% |
PPAR gamma | + | 0.7368 | 73.68% |
Honey bee toxicity | - | 0.7324 | 73.24% |
Biodegradation | - | 0.8250 | 82.50% |
Crustacea aquatic toxicity | + | 0.5700 | 57.00% |
Fish aquatic toxicity | + | 0.8255 | 82.55% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
No proven targets yet! |
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL2581 | P07339 | Cathepsin D | 99.79% | 98.95% |
CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 99.03% | 97.64% |
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 98.10% | 96.09% |
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 97.81% | 91.11% |
CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 97.75% | 96.67% |
CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 97.56% | 98.24% |
CHEMBL1921 | P47901 | Vasopressin V1b receptor | 97.48% | 92.50% |
CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 96.85% | 94.45% |
CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 96.69% | 95.56% |
CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 96.35% | 82.69% |
CHEMBL4040 | P28482 | MAP kinase ERK2 | 95.66% | 83.82% |
CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 95.62% | 93.10% |
CHEMBL2514 | O95665 | Neurotensin receptor 2 | 95.47% | 100.00% |
CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 94.82% | 93.00% |
CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 94.42% | 97.23% |
CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 94.09% | 90.08% |
CHEMBL221 | P23219 | Cyclooxygenase-1 | 93.96% | 90.17% |
CHEMBL3137262 | O60341 | LSD1/CoREST complex | 93.62% | 97.09% |
CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 93.28% | 97.14% |
CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 92.91% | 97.25% |
CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 92.70% | 82.38% |
CHEMBL4227 | P25090 | Lipoxin A4 receptor | 91.99% | 100.00% |
CHEMBL3230 | O95977 | Sphingosine 1-phosphate receptor Edg-6 | 91.95% | 94.01% |
CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 91.65% | 98.33% |
CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 91.47% | 95.89% |
CHEMBL2327 | P21452 | Neurokinin 2 receptor | 91.42% | 98.89% |
CHEMBL4101 | P17612 | cAMP-dependent protein kinase alpha-catalytic subunit | 90.74% | 82.86% |
CHEMBL5805 | Q9NR97 | Toll-like receptor 8 | 90.73% | 96.25% |
CHEMBL5852 | Q96P65 | Pyroglutamylated RFamide peptide receptor | 90.57% | 85.00% |
CHEMBL206 | P03372 | Estrogen receptor alpha | 90.14% | 97.64% |
CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 90.10% | 95.89% |
CHEMBL1255126 | O15151 | Protein Mdm4 | 89.96% | 90.20% |
CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 89.85% | 99.17% |
CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 89.76% | 95.00% |
CHEMBL3384 | Q16512 | Protein kinase N1 | 89.56% | 80.71% |
CHEMBL2073 | P07947 | Tyrosine-protein kinase YES | 89.49% | 83.14% |
CHEMBL3892 | Q99500 | Sphingosine 1-phosphate receptor Edg-3 | 89.18% | 97.29% |
CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 89.07% | 88.56% |
CHEMBL3091268 | Q92753 | Nuclear receptor ROR-beta | 88.97% | 95.50% |
CHEMBL4578 | Q14680 | Maternal embryonic leucine zipper kinase | 88.56% | 81.58% |
CHEMBL1293287 | P14735 | Insulin-degrading enzyme | 87.49% | 88.10% |
CHEMBL340 | P08684 | Cytochrome P450 3A4 | 87.42% | 91.19% |
CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 86.61% | 100.00% |
CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 86.61% | 96.47% |
CHEMBL4208 | P20618 | Proteasome component C5 | 86.55% | 90.00% |
CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 86.37% | 88.42% |
CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 85.49% | 95.71% |
CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 84.31% | 93.56% |
CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 83.97% | 90.71% |
CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 83.85% | 94.66% |
CHEMBL5261 | Q7L7X3 | Serine/threonine-protein kinase TAO1 | 83.41% | 89.33% |
CHEMBL5701 | Q9H2K8 | Serine/threonine-protein kinase TAO3 | 82.37% | 96.67% |
CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 81.40% | 94.00% |
CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 81.10% | 100.00% |
CHEMBL4296 | Q15858 | Sodium channel protein type IX alpha subunit | 80.27% | 96.11% |
CHEMBL2035 | P08912 | Muscarinic acetylcholine receptor M5 | 80.20% | 94.62% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
Justicia adhatoda |